Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | SQLE | Q14534 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2725711 | 1.00 | KMT2A (0.59) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9874540 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9872878 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL11072220 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9873705 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9872875 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9873716 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL11072225 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL9874537 | 0.98 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT | |
| SCHEMBL2727334 | 0.85 | KMT2A (0.61) | KMT2AALOX15MEN1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4064150-A | SELECTIVE GAMMA-ALKYLATION OF ALPHA,BETA-UNSATURATED ACIDS WITH ALLYLIC ELECTROPHILES, DICOPPER(I) DIENOLATES | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1977-12-20 | — | — | US | claimed |
| JP-56113718-A | — | — | None | — | — | JP | disclosed |
| US-12215126-B2 | Cationic steroidal antimicrobial compounds with endogenous groups | BRIGHAM YOUNG UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |
| US-12042550-B2 | Leave-on hair treatment compositions | L'OREAL (FR) | 2024-07-23 | — | — | US | disclosed |
| US-20240156699-A1 | HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2024-05-16 | — | — | US | disclosed |
| WO-2024097630-A1 | HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2024-05-10 | — | — | WO | disclosed |
| US-20240122821-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | L'OREAL (FR) | 2024-04-18 | — | — | US | disclosed |
| US-20240122833-A1 | METHOD FOR REMOVING COLOR FROM ARTIFICIALLY COLORED HAIR | L'OREAL (FR) | 2024-04-18 | — | — | US | disclosed |
| EP-4346747-A1 | COSMETIC COMPOSITION COMPRISING VITAMIN C | L'OREAL (FR) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024073637-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | L'OREAL (FR) | 2024-04-04 | — | — | WO | disclosed |
| US-6303654-B1 | EXPOSING TUMOR CELLS TO FARNESYL ANTHRANILATE AND CARRIER TO INHIBIT OR REDUCE TUMOR CELL GROWTH | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-10-16 | — | — | US | disclosed |
| US-6207705-B1 | FOR KILLING INSECTS, TICKS, NEMATODES, THEIR EGGS AND LARVE; VOLATALITY, FUMICATION, NONTOXIC | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2001-03-27 | — | — | US | disclosed |
| WO-2001008653-A1 | SKIN CARE COMPOSITION | UNILEVER PLC (GB) | 2001-02-08 | — | — | WO | disclosed |
| EP-1061907-A1 | MONOTERPENOID DERIVATIVES FOR TREATMENT OF CANCER | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-1999045912-A1 | MONOTERPENOID DERIVATIVES FOR TREATMENT OF CANCER | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-09-16 | — | — | WO | disclosed |
| US-4992469-A | Prevention of cardiovascular disorder; phospholipase inhibitor | EISAI CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| EP-0163317-B1 | QUINONE DERIVATIVES, METHOD AND USE OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION | Eisai Co., Ltd. (JP) | 1988-08-24 | — | — | EP | disclosed |
| EP-0163317-A1 | Quinone derivatives, method and use of preparing same, and pharmaceutical composition | Eisai Co., Ltd. (JP) | 1985-12-04 | — | — | EP | disclosed |
| JP-S56113718-A | BIFUNCTIONAL TERPENOID, ITS PREPARATION, AND ULCER PREVENTIVE AGENT COMPRISING IT | AGENCY OF IND SCIENCE & TECHNOL | 1981-09-07 | — | — | JP | disclosed |
| US-4064150-A | SELECTIVE GAMMA-ALKYLATION OF ALPHA,BETA-UNSATURATED ACIDS WITH ALLYLIC ELECTROPHILES, DICOPPER(I) DIENOLATES | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042550-B2 | Leave-on hair treatment compositions | ALG3, DEGS1, DSG1 | KMT2A 3194/4885ALOX15 106/4885MEN1 538/4885 |
| US-20240122821-A1 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | ALG3, DEGS1, DSG1 | KMT2A 3194/4885ALOX15 106/4885MEN1 538/4885 |
| US-20240156699-A1 | HAIR TREATMENT COMPOSITION | DEGS1, POLR1C, PHOSPHO1 | KMT2A 986/4885ALOX15 1770/4885MEN1 710/4885 |
| US-12215126-B2 | Cationic steroidal antimicrobial compounds with endogenous groups | FPR3, NR3C2, HSD17B7 | KMT2A 4660/4885ALOX15 312/4885MEN1 3278/4885 |
| US-20240122833-A1 | METHOD FOR REMOVING COLOR FROM ARTIFICIALLY COLORED HAIR | TYR, COXFA4L2, CAT | KMT2A 297/4885ALOX15 3382/4885MEN1 3963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.